v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (27,696) $ (10,860)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 60 68
Stock-based compensation expense 226 1,389
Non-cash lease expense 292 267
Non-cash interest and other expense, net 0 36
Acquired in-process research and development 19,927 0
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (71) 231
Accounts payable (454) (263)
Accrued expenses and other liabilities 405 1,215
Interest payable 0 (23)
Operating lease liabilities (287) (96)
Cash used in operating activities (7,598) (8,036)
Investing activities:    
Purchase of property and equipment 0 0
Cash used in investing activities 0 0
Financing activities:    
Proceeds from issuance of common stock, pre-funded warrants and common stock warrants, net of issuance costs 1,272 1,443
Proceeds from issuance of common stock and common stock warrants to related party net of issuance costs 424  
Repayment of loan 0 (2,198)
Proceeds from the issuance of common stock under equity plan awards 0 34
Cash provided by (used in) financing activities 1,696 (721)
Net decrease in cash, cash equivalents and restricted cash (5,902) (8,757)
Cash, cash equivalents and restricted cash at beginning of period 8,150 30,711
Cash, cash equivalents and restricted cash at end of period 2,248 21,954
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 0 $ 148